Acadia pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4)

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced that on may 15, 2024, the compensation committee of acadia's board of directors (the “committee”) granted inducement awards consisting of non-qualified stock options to purchase 57,252 shares of common stock and 33,675 restricted stock units (“rsus”) to twenty-two new employees under acadia's 2023 inducement plan. the compensation committee approved the awards as an inducement material to the new employees' e.
ACAD Ratings Summary
ACAD Quant Ranking